Pura Vida Investments, LLC Relmada Therapeutics, Inc. Transaction History

Pura Vida Investments, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$2.17 - $35.84 $48,245 - $796,830	22,233 New	22,233 $77,000
Q2 2022 Aug 15, 2022	SELL	$16.5 - $30.34 $245,602 - $451,610	-14,885 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$16.72 - $26.99 $1,672 - $2,699	100 Added 0.68%	14,885 $402,000
Q4 2021 Feb 14, 2022	BUY	$16.93 - $26.82 $250,310 - $396,533	14,785 New	14,785 $333,000

12.3M

229K

138K

Ticker RLMD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 28,608,500
Market Cap $10.9M
Description
Relmada Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing various products for the treatment of central nervous system (CNS) diseases and other disorders. Its lead product candidate is Esmethadone (d-methadone, dextromethadone, and REL-1017), a new chemical entity and N-methyl-D-aspartate receptor antagonist that ...

Get notified when there are updates to the investment portfolio of Pura Vida Investments, LLC, based on Form 13F filings with the SEC.

Stay updated on Pura Vida Investments, LLC with notifications on news.